Ackermans&van Haaren

Belgian startup Indigo Diabetes scores €38 million to develop its under the skin CGM sensor
By Laura Lovett | 03:04 pm | July 27, 2020
The company is looking to test the product in the U.S. and Europe, with the goal of gaining market approval for both regions by 2023.